Erythema nodosum and non-Hodgkin's lymphoma.
We describe a case of erythema nodosum associated with non-Hodgkin's lymphoma. The course and resolution of the erythema nodosum correlated most closely with a breakdown and release of new antigen at the start of a new regimen of chemotherapy.
Thomson
G T
GT
Section of Rheumatology, Wellesley Hospital, Toronto, Canada.
Keystone
E C
EC
Sturgeon
J F
JF
Fornasier
V
V
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000150:complications* / Q000473:pathology; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology; D002955:Leucovorin / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use; D010489:Periarthritis / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use
D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate